234 related articles for article (PubMed ID: 30447929)
1. Antithrombotic medication in cancer-associated thrombocytopenia: Current evidence and knowledge gaps.
Leader A; Ten Cate H; Spectre G; Beckers EAM; Falanga A
Crit Rev Oncol Hematol; 2018 Dec; 132():76-88. PubMed ID: 30447929
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant and antiplatelet treatment in cancer patients with thrombocytopenia.
Leader A; Gurevich-Shapiro A; Spectre G
Thromb Res; 2020 Jul; 191 Suppl 1():S68-S73. PubMed ID: 32736782
[TBL] [Abstract][Full Text] [Related]
3. [Which anticoagulant or antiplatelet treatment for cancer patients with thrombocytopenia ?].
Paoletti M; Azizi MA; Efthymiou A
Rev Med Suisse; 2023 Feb; 19(813):281-285. PubMed ID: 36753345
[TBL] [Abstract][Full Text] [Related]
4. Between Scylla and Charybdis: antithrombotic therapy in hematopoietic progenitor cell transplant patients.
Deloughery TG
Bone Marrow Transplant; 2012 Oct; 47(10):1269-73. PubMed ID: 21909143
[TBL] [Abstract][Full Text] [Related]
5. Antithrombotic drugs for the treatment of heparin-induced thrombocytopenia.
Jeske WP; Walenga JM
Curr Opin Investig Drugs; 2002 Aug; 3(8):1171-80. PubMed ID: 12211410
[TBL] [Abstract][Full Text] [Related]
6. Balancing the risk of complications in foot and ankle surgical patients taking antithrombotic medication.
Miller S; Nitzki-George D; Caprini JA
Foot Ankle Spec; 2014 Dec; 7(6):507-14. PubMed ID: 25053792
[TBL] [Abstract][Full Text] [Related]
7. Individualized antithrombotic therapy.
Lüscher TF; Steffel J
Hamostaseologie; 2016; 36(1):26-32. PubMed ID: 25597592
[TBL] [Abstract][Full Text] [Related]
8. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
Thompson PL; Verheugt FW
Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
[TBL] [Abstract][Full Text] [Related]
9. Antithrombotic regimens in patients with indication for long-term anticoagulation undergoing coronary interventions-systematic analysis, review of literature, and implications on management.
Deshmukh A; Hilleman DE; Del Core M; Nair CK
Am J Ther; 2013; 20(6):654-63. PubMed ID: 21519218
[TBL] [Abstract][Full Text] [Related]
10. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP
Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284
[TBL] [Abstract][Full Text] [Related]
11. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy.
Manchikanti L; Falco FJ; Benyamin RM; Caraway DL; Kaye AD; Helm S; Wargo BW; Hansen H; Parr AT; Singh V; Swicegood JR; Smith HS; Schultz DM; Malla Y; Hirsch JA
Pain Physician; 2013 Apr; 16(2 Suppl):SE261-318. PubMed ID: 23615893
[TBL] [Abstract][Full Text] [Related]
12. Management and outcomes of cancer-associated venous thromboembolism in patients with concomitant thrombocytopenia: a retrospective cohort study.
Kopolovic I; Lee AY; Wu C
Ann Hematol; 2015 Feb; 94(2):329-36. PubMed ID: 25190031
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic medication for stroke prevention.
Weimar C; Weber R; Diener HC
Expert Rev Cardiovasc Ther; 2009 Oct; 7(10):1245-54. PubMed ID: 19814667
[TBL] [Abstract][Full Text] [Related]
14. Optimizing selection of antithrombotic therapy in patients requiring PCI and long term anticoagulation.
Mallikarjuna Rao Edupuganti M; Marmagkiolis K; Cilingiroglu M; Uretsky BF; Hakeem A
Cardiovasc Revasc Med; 2014; 15(8):414-20. PubMed ID: 25204491
[TBL] [Abstract][Full Text] [Related]
15. Residential medication management reviews of antithrombotic therapy in aged care residents with atrial fibrillation: assessment of stroke and bleeding risk.
Nishtala PS; Castelino RL; Peterson GM; Hannan PJ; Salahudeen MS
J Clin Pharm Ther; 2016 Jun; 41(3):279-84. PubMed ID: 27062272
[TBL] [Abstract][Full Text] [Related]
16. Antithrombotic and Anticoagulant Therapy for Atrial Fibrillation.
Dzeshka MS; Lip GY
Heart Fail Clin; 2016 Apr; 12(2):257-71. PubMed ID: 26968670
[TBL] [Abstract][Full Text] [Related]
17. Management of antithrombotic therapies in patients scheduled for eye surgery.
Bonhomme F; Hafezi F; Boehlen F; Habre W
Eur J Anaesthesiol; 2013 Aug; 30(8):449-54. PubMed ID: 23698703
[TBL] [Abstract][Full Text] [Related]
18. Antithrombotic therapy for heart failure in sinus rhythm.
Subramaniam V; Davis RC; Shantsila E; Lip GY
Fundam Clin Pharmacol; 2009 Dec; 23(6):705-17. PubMed ID: 19735305
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention.
Pareek M; Bhatt DL; Ten Berg JM; Kristensen SD; Grove EL
Expert Opin Pharmacother; 2017 Jun; 18(9):875-883. PubMed ID: 28489475
[TBL] [Abstract][Full Text] [Related]
20. [Antithrombotic prophylaxis in patients with ventricular dysfunction: critical review of the literature and new perspectives].
Scardi S; Mazzone C
Ital Heart J Suppl; 2003 Mar; 4(3):201-9. PubMed ID: 12784754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
